Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberta De Domenico"'
Autor:
Rosario D'Anna, Giovanni Baviera, Roberta Granese, Nella Dugo, Saveria Chimicata, Camillo Carbone, Roberta De Domenico
Publikováno v:
Clinical Chemistry. 56:1355-1357
To the Editor: ADAM12s1 (a disintegrin and metalloprotease 12s), a placenta-derived glycoprotein involved in tissue growth and differentiation, has been shown to be an early screening marker for trisomy 21 before the 10th week of gestation (1) and a
Autor:
Oriana, Valenti, Fosca A F, Di Prima, Eliana, Renda, Marianna, Faraci, Entela, Hyseni, Roberta, De Domenico, Santo, Monte, Elsa, Giorgio
Publikováno v:
Journal of prenatal medicine. 5(3)
Chromosomally normal first trimester fetuses with an increased nuchal translucency measurement have an elevated risk of congenital heart defect (CHD). so there is an increased demand for imaging the fetal heart during the first and early second trime
Autor:
Fosca A F, Di Prima, Oriana, Valenti, Entela, Hyseni, Elsa, Giorgio, Marianna, Faraci, Eliana, Renda, Roberta, De Domenico, Santo, Monte
Publikováno v:
Journal of prenatal medicine. 5(2)
Obstetric complications are the hallmark of antiphospholipid syndrome. Recurrent miscarriage, early delivery, oligohydramnios, prematurity, intrauterine growth restriction, fetal distress, fetal or neonatal thrombosis, pre-eclampsia/eclampsia, HELLP
Autor:
Santo, Monte, Oriana, Valenti, Elsa, Giorgio, Eliana, Renda, Entela, Hyseni, Marianna, Faraci, Roberta, De Domenico, Fosca A F, Di Prima
Publikováno v:
Journal of prenatal medicine. 5(2)
Obesity has become a serious global public health issue and has consequences for nearly all areas of medicine. Within obstetrics, obesity not only has direct implications for the health of a pregnancy but also impacts on the weight of the child in in
Autor:
Marianna, Faraci, Fosca A F, Di Prima, Oriana, Valenti, Entela, Hyseni, Santo, Monte, Elsa, Giorgio, Roberta, De Domenico
Publikováno v:
Journal of prenatal medicine. 5(3)
Our report aims to verify whether perinatal maternal glycemic control in gestational diabetes can only be achieved with insulin or with oral hypoglycaemic agents. Then we want to evaluate the efficacy and safety of oral hypoglycemic agents in the tre